Caroline Aspord

17PUBLICATIONS
30CO-AUTHORS
Haematological tumoursInnate immunityPredictive and prognostic markersMedical devicesMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Aug 05, 2026
Metabolic Profiling of Circulating and Tumour-Infiltrating T Cells Uncovers Bioenergetic Checkpoints Linked With Immune and Clinical Skewing in Melanoma Patients.

|Mar 20, 2026
[Metabolic rewiring of dendritic cells to re-invigorate antitumor immunity].

Caroline Aspord, Camille Niveau, Philippe Saas

|Apr 18, 2025
Soluble VE-cadherin as a biomarker of response to immunotherapy by anti-PD1 in metastatic melanoma.

Clémentine Broche, Khémary Um, Isabelle Vilgrain

|Jan 29, 2025
HBV and HBsAg strongly reshape the phenotype, function, and metabolism of DCs according to patients' clinical stage.

Lucile Dumolard, Theophile Gerster, Florent Chuffart

|Jan 27, 2025
MCT1 lactate transporter blockade re-invigorates anti-tumor immunity through metabolic rewiring of dendritic cells in melanoma.

Camille Niveau, Mélanie Cettour-Cave, Stéphane Mouret

|May 14, 2024
Glycans in melanoma: Drivers of tumour progression but sweet targets to exploit for immunotherapy.

Camille Niveau, Eleonora Sosa Cuevas, Philippe Saas

Pageof 3

Frequent Collaborators

7 joint publications

Eleonora Sosa Cuevas

5 joint publications

Philippe Saas

3 joint publications

Nathalie Bendriss-Vermare

2 joint publications

David Laurin